ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO897

The European Kidney Function Consortium Estimating Glomerular Filtration Rate Equation for Cystatin C: Results for Europe, the United States, and Africa

Session Information

Category: Pathology and Lab Medicine

  • 1700 Pathology and Lab Medicine

Authors

  • Delanaye, Pierre, CHU de Liege - Hopital du Sart Tilman, Liege, Liège, Belgium
  • Björk, Jonas, Skanes universitetssjukhus Lund, Lund, Skåne, Sweden
  • Ebert, Natalie, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Eriksen, Bjorn Odvar, UiT Norges arktiske universitet, Tromso, Tromso, Norway
  • Vidal-Petiot, Emmanuelle, Hopital Bichat - Claude-Bernard, Paris, Île-de-France, France
  • Grubb, Anders O., Skanes universitetssjukhus Lund, Lund, Skåne, Sweden
  • Hansson, Magnus Daniel, Karolinska Institutet, Stockholm, Stockholm, Sweden
  • Littmann, Karin, Karolinska Institutet, Stockholm, Stockholm, Sweden
  • Melsom, Toralf, UiT Norges arktiske universitet, Tromso, Tromso, Norway
  • Rule, Andrew D., Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Schaeffner, Elke, Charite Universitatsmedizin Berlin, Berlin, Berlin, Germany
  • Sundin, Per-Ola, Orebro universitet, Orebro, Örebro, Sweden
  • Åkesson, Anna, Skanes universitetssjukhus Lund, Lund, Skåne, Sweden
  • Larsson, Anders, Uppsala Universitet, Uppsala, Sweden
  • Cavalier, Etienne, CHU de Liege - Hopital du Sart Tilman, Liege, Liège, Belgium
  • Bukabau, Justine Busanga, Universite de Kinshasa, Kinshasa, Congo (the Democratic Republic of the)
  • Sumaili, Ernest Kiswaya, Universite de Kinshasa, Kinshasa, Congo (the Democratic Republic of the)
  • Flamant, Martin, Hopital Bichat - Claude-Bernard, Paris, Île-de-France, France
  • Nyman, Ulf, Skanes universitetssjukhus Lund, Lund, Skåne, Sweden
  • Pottel, Hans, Katholieke Universiteit Leuven - Campus Kulak Kortrijk, Kortrijk, Flanders, Belgium

Group or Team Name

  • EKFC (European Kidney Function Consortium)
Background

The creatinine based European Kidney Function Consortium (EKFCCrea) equation was recently developed as an optimized full age spectrum equation. In the present study, the new EKFC-equation is applied to serum cystatin C (CysC), by replacing rescaled SCr by rescaled CysC.

Methods

Individual data from Sweden (n=243,218) were used to estimate the scaling or normalization factor (Q’) for CysC in adults. Scaled SCr/Q was replaced by scaled CysC/Q’ in the cystatin C based EKFC-equation (EKFCCysC) which was then validated in White and Black subjects from Europe (n=11,231), North America (n=1,093) and Africa (n=508), with measured GFR, SCr, CysC, age, and gender available.

Results

Rescaling factor Q’ for CysC was estimated at 0.79 for adult females and 0.86mg/L for adult males until age 50 years, and (0.79 or 0.86) + 0.005 x (Age – 50) thereafter. A sex-independent scaling factor of 0.83mg/L (and 0.83 + 0.005 x (Age – 50) ) was also evaluated. EKFCCysC was (nearly) unbiased and showed prediction performances similar to EKFCCrea in White Europeans, White North Americans, Black Europeans and Black Africans (P10/P30 equal to 40%/85%). EKFCCysC was superior to the KDIGO recommended equation CKD-EPICrea and CKD-EPICysC. P10/P30 of the arithmetic mean of EKFCCrea and EKFCCysC was greater than 45%/90% in almost all age-subgroups.

Conclusion

In our mixed cohorts from Europe, North America and Africa, EKFCCysC has the same mathematical form as EKFCCrea, with different scaling factors for cystatin C and shows similar performance as EKFCCrea, and better performance than CKD-EPICysC. Moreover, the EKFCCysC equation is independent of race and gender. An extra gain in accuracy (reduced bias, plus 5 percentage points in P10/P30 accuracy) is achieved by combining both EKFC-equations.